United States (US) Biopsy Devices Market Outlook to 2033: Biopsy Guns, Biopsy Needles, Vacuum-Assisted Needle Devices and Others

All the vital news, analysis, and commentary curated by our industry experts.

$4995

Buy Report

Published: June 23, 2025 Report Code: GDME25375CCDB-ST

Report Overview
Key Players
Table of Contents
Table
Figures

GlobalData’s “United States Biopsy Devices Market Outlook to 2033” is a comprehensive databook report, covering key market data on the United States Biopsy Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Biopsy Guns, Biopsy Needles, Vacuum-Assisted Needle Devices, Biopsy Forceps and Biopsy Punches

The United States Biopsy Devices Market report provides key information and data on –
• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
• 2024 company share data for Biopsy Devices Market.
• Global corporate-level profiles of key companies operating within the United States Biopsy Devices Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

United States Biopsy Devices is segmented as follows – _x000D_

• Biopsy Guns_x000D_

• Biopsy Needles_x000D_

• Vacuum-Assisted Needle Devices_x000D_

• Biopsy Forceps_x000D_

• Biopsy Punches

Reasons to Buy

The United States Biopsy Devices Market report helps you to develop –

• Business strategies by identifying the key market segments poised for strong growth in the future.

• Market-entry and market expansion strategies.

• Design competition strategies by identifying who-stands-where in the market.

• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

• Understand the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Acuderm Inc

|1 Table of Contents 3

|1.1 List of Tables 5

|1.2 List of Figures 5

2 Introduction 6

2.1 What Is This Report About? 6

2.2 Biopsy Devices Market Segmentation 6

2.3 Definitions of Markets Covered in the Report 7

3 Biopsy Devices Market, United States 9

3.1 Biopsy Devices Market, United States, Revenue ($m), 2018-2033 9

3.1.1 Biopsy Forceps Market, United States, Revenue ($m), by Segment, 2018-2033 11

3.1.2 Biopsy Guns Market, United States, Revenue ($m), by Segment, 2018-2033 13

3.1.3 Biopsy Needles Market, United States, Revenue ($m), by Segment, 2018-2033 15

3.1.4 Biopsy Punches Market, United States, Revenue ($m), by Segment, 2018-2033 17

3.1.5 Vacuum-Assisted Needle Devices Market, United States, Revenue ($m), by Segment, 2018-2033 19

3.2 Biopsy Devices Market, United States, Volume (Units), 2018-2033 21

3.2.1 Biopsy Forceps Market, United States, Volume (Units), by Segment, 2018-2033 24

3.2.2 Biopsy Guns Market, United States, Volume (Units), by Segment, 2018-2033 26

3.2.3 Biopsy Needles Market, United States, Volume (Units), by Segment, 2018-2033 28

3.2.4 Biopsy Punches Market, United States, Volume (Units), by Segment, 2018-2033 31

3.2.5 Vacuum-Assisted Needle Devices Market, United States, Volume (Units), by Segment, 2018-2033 33

3.3 Biopsy Devices Market, United States, Average Price ($) , 2018-2033 35

3.4 Biopsy Devices Market, United States, Company Share by Revenue ($m), 2024 37

4 Overview of Key Companies in United States, Biopsy Devices Market 39

4.1 Becton Dickinson and Co 39

4.1.1 Company Overview 39

4.2 Hologic Inc 39

4.2.1 Company Overview 39

4.3 Boston Scientific Corp 39

4.3.1 Company Overview 39

4.4 Argon Medical Devices Inc 39

4.4.1 Company Overview 39

4.5 Merit Medical Systems Inc 40

4.5.1 Company Overview 40

4.6 Olympus Corp 40

4.6.1 Company Overview 40

4.7 Devicor Medical Products Inc 40

4.7.1 Company Overview 40

4.8 Medtronic Plc 40

4.8.1 Company Overview 40

4.9 Wilson-Cook Medical Inc 41

4.9.1 Company Overview 41

4.10 Integra LifeSciences Holdings Corp 41

4.10.1 Company Overview 41

5 Biopsy Devices Market Pipeline Products 42

6 Financial Deals Landscape 44

6.1 Debt Offerings 44

6.1.1 Stryker Raises USD883.83 Million Public Offering of

3.375% Notes Due 2032 44

6.1.2 Stryker Raises USD662.87 Million in Public Offering of

3.625% Notes Due 2036 46

7 Recent Developments 47

7.1 Corporate Communications 47

7.1.1 Feb 18, 2025: Industry Leaders Join Mizzou Cybersecurity Advisory Board 47

7.1.2 Dec 09, 2024: Hologic Appoints Dr. Martin Madaus to Its Board 47

7.2 Financial Announcements 47

7.2.1 Mar 19, 2025: iCAD Posts Results for Q4 and Fiscal Year Ended December 31, 2024 47

7.2.2 Feb 05, 2025: Hologic Reports Results for Q1 of Fiscal 2025 49

7.2.3 Jan 06, 2025: Hologic to Announce Financial Results for the First Quarter of Fiscal 2025 on Wednesday, February 5, 2025 50

7.2.4 Dec 19, 2024: Cardinal Health to Announce Second-Quarter Results for Fiscal Year 2025 on January 30 50

7.2.5 Nov 01, 2024: Cardinal Health Announces Q1 Fiscal Year 2025 Results 50

7.2.6 Oct 23, 2024: Boston Scientific Reports Results for Q3 2024 51

7.2.7 Oct 08, 2024: Merit Medical Systems to Announce Third Quarter 2024 Results on October 30, 2024 52

7.2.8 Oct 04, 2024: Hologic to Announce Financial Results for the Fourth Quarter of Fiscal 2024 on Monday, November 4, 2024 52

7.2.9 Oct 02, 2024: Boston Scientific Announces Conference Call Discussing Third Quarter 2024 Results 53

7.2.10 Oct 01, 2024: Stryker to Announce Its Third Quarter 2024 Financial Results 53

7.2.11 Aug 14, 2024: Cardinal Health Reports Fourth Quarter and Fiscal Year 2024 Results and Raises Fiscal Year 2025 Guidance 53

7.2.12 Aug 01, 2024: Merit Medical Systems Announces Q2 2024 Results and Raises Full-Year Guidance 54

7.2.13 Jul 01, 2024: Stryker to Announce Financial Results for its Second Quarter of Fiscal Year 2024 55

7.2.14 Jun 18, 2024: Merit Medical Systems to Announce Second Quarter 2024 Results on August 1, 2024 56

7.3 Government and Public Interest 56

7.3.1 Jan 14, 2025: NFCR-Supported Scientists Advance Liquid Biopsy Technology 56

7.3.2 Jan 06, 2025: FDA Issues Draft Guidance on Including Tissue Biopsies in Clinical Trials 57

7.3.3 Sep 30, 2024: Study Advocates for Alternative Biopsy Approach to Detecting Prostate Cancer 57

7.3.4 Jul 09, 2024: BioCryst : ORLADEYO (Berotralstat) Approved in Peru 58

7.4 Other Significant Developments 58

7.4.1 Jan 27, 2025: UC Davis Health places order for BiBBInstruments' EndoDrill GI cancer care device 58

7.4.2 Aug 15, 2024: Alpenglow Biosciences And Partners Secure A Total Of $24m For Development Of Alpenglow’s 3d Spatial Pathology Platform 59

7.5 Product News 60

7.5.1 Nov 13, 2024: Fifteen Radiology Partners Physicians Participating in Multiple RSNA 2024 Sessions 60

7.5.2 Nov 11, 2024: Syndeo Medical Announces European MDR Approval for Two Product Brands 62

7.5.3 Sep 19, 2024: Northwestern Medicine Study Advocates for Alternative Biopsy Approach for Detecting Prostate Cancer 63

7.5.4 Sep 13, 2024: Endo Presents Data at the American Orthopaedic Foot & Ankle Society Annual Meeting 63

8 Appendix 65

8.1 Research Methodology 66

8.1.1 Coverage 66

8.1.2 Secondary Research 66

8.1.3 Primary Research 67

8.1.4 Market Modeling and Forecasting 68

8.1.5 Company Share Analysis 69

8.1.6 Benchmarking 70

8.2 GlobalData Consulting 70

8.3 Contact Us 70

8.4 Disclaimer 71

Table

Table 1: Biopsy Devices Market, United States, Revenue ($m), USD Constant, 2018-2033 10

Table 2: Biopsy Forceps Market, United States, Revenue ($m), USD Constant, 2018-2033 12

Table 3: Biopsy Guns Market, United States, Revenue ($m), USD Constant, 2018-2033 14

Table 4: Biopsy Needles Market, United States, Revenue ($m), USD Constant, 2018-2033 16

Table 5: Biopsy Punches Market, United States, Revenue ($m), USD Constant, 2018-2033 18

Table 6: Vacuum-Assisted Needle Devices Market, United States, Revenue ($m), USD Constant, 2018-2033 20

Table 7: Biopsy Devices Market, United States, Volume (Units), 2018-2033 22

Table 8: Biopsy Forceps Market, United States, Volume (Units), 2018-2033 25

Table 9: Biopsy Guns Market, United States, Volume (Units), 2018-2033 27

Table 10: Biopsy Needles Market, United States, Volume (Units), 2018-2033 29

Table 11: Biopsy Punches Market, United States, Volume (Units), 2018-2033 32

Table 12: Vacuum-Assisted Needle Devices Market, United States, Volume (Units), 2018-2033 34

Table 13: Biopsy Devices Market, United States, Average Price ($), 2018-2033 35

Table 14: Biopsy Devices Market, United States, Company Share by Revenue ($m), 2024 38

Table 15: Biopsy Devices Market Pipeline Products 42

Table 16: Stryker Raises USD883.83 Million Public Offering of 3.375% Notes Due 2032 44

Table 17: Stryker Raises USD662.87 Million in Public Offering of 3.625% Notes Due 2036 46

Table 18: Total Number of Primary Research Participants, General Surgery Devices Market, by Country 67

Figures

Figure 1: Biopsy Devices Market, United States, Revenue ($m), USD Constant, 2018-2033 9

Figure 2: Biopsy Forceps Market, United States, Revenue ($m), USD Constant, 2018-2033 11

Figure 3: Biopsy Guns Market, United States, Revenue ($m), USD Constant, 2018-2033 13

Figure 4: Biopsy Needles Market, United States, Revenue ($m), USD Constant, 2018-2033 15

Figure 5: Biopsy Punches Market, United States, Revenue ($m), USD Constant, 2018-2033 17

Figure 6: Vacuum-Assisted Needle Devices Market, United States, Revenue ($m), USD Constant, 2018-2033 19

Figure 7: Biopsy Devices Market, United States, Volume (Units), 2018-2033 21

Figure 8: Biopsy Forceps Market, United States, Volume (Units), 2018-2033 24

Figure 9: Biopsy Guns Market, United States, Volume (Units), 2018-2033 26

Figure 10: Biopsy Needles Market, United States, Volume (Units), 2018-2033 28

Figure 11: Biopsy Punches Market, United States, Volume (Units), 2018-2033 31

Figure 12: Vacuum-Assisted Needle Devices Market, United States, Volume (Units), 2018-2033 33

Figure 13: Biopsy Devices Market, United States, Company Share (%), 2024 37

United States (US) Biopsy Devices Market Outlook to 2033: Biopsy Guns, Biopsy Needles, Vacuum-Assisted Needle Devices and Others standard reports

Currency USD

Single User

$4,995

Can be used by individual purchaser only

Undecided about purchasing this report?

Enquire Before Buying

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise. The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS

Related reports

View more General Surgery reports

Medical Devices

New

Adult Feeding Tubes and Formula Market Size by Segments, Share,…

Medical Devices

New

Neurovascular Thrombectomy Devices Market Size by Segments, Share, Regulatory, Reimbursement,…

Medical Devices

New

Body Contouring Devices Market Size by Segments, Share, Regulatory, Reimbursement,…

Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at United States (US) Biopsy Devices Market Outlook to 2033: Biopsy Guns, Biopsy Needles, Vacuum-Assisted Needle Devices and Others in real time.

Access a live United States (US) Biopsy Devices Market Outlook to 2033: Biopsy Guns, Biopsy Needles, Vacuum-Assisted Needle Devices and Others dashboard for 12 months, with up-to-the-minute insights.
Fuel your decision making with real-time deal coverage and media activity.
Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.

Tell me more

Reports

Reports by Sector

Report Type

United States (US) Biopsy Devices Market Outlook to 2033: Biopsy Guns, Biopsy Needles, Vacuum-Assisted Needle Devices and Others

Scope

Reasons to Buy

Table of Contents

Table

Figures

Undecided about purchasing this report?

Get in touch to find out about multi-purchase discounts

Related reports